Leprosy after starting antiretroviral treatment: An increasingly reported clinical problem but not a serious public health risk

British Medical Journal

Volumn 334, Issue 7587, 2007, Pages 217-218

  Lawn, Stephen D ^a   Lockwood, Diana N J ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE ASSOCIATION; EDITORIAL; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LEPROSY; LEPROSY CONTROL; OPPORTUNISTIC INFECTION; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; STIGMA;

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; LEPROSY; PUBLIC HEALTH; RISK FACTORS;

EID: 33846877619     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39107.480359.80     Document Type: Editorial

References (11)

1. Worrisome new link: AIDS drugs and leprosy. New York Times 2006 October 24. http://query.nytimes.com/search/query?d=nytdsecti on%2b&o=e%2b&v=Health%2b&c=a%2b&query=Leprosy&dat e_select=full.
2. Shelburne SA III, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003;5:67-79.
3. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006;6:350-60.
4. Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2003;36:e5-6.
5. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005;5:361-73.
6. Couppie P, Abel S, Voinchet H, Roussel M, Helenon R, Huerre M, et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004;140:997-1000.
7. Lawn SD, Wilkinson RJ. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol 2006; 28:625-33.
8. Anon. Global leprosy situation, 2006. Wkly Epidemiol Rec 2006;81:309-16.
9. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among patients accessing a community-based antiretroviral programme in South Africa: implications for programme design. AIDS 2005;19:2141-8.
10. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in Africa. AIDS 2007 (in press).
11. WHO. Press release: HIV infection rates decreasing in several countries but global number of people living with HIV continues to rise. November 2005. www.who.int/hiv/epiupdate2005/en/print. html.